Abstract PS4-08: Biomarker analysis of paclitaxel, ganitumab, and metformin (PGM) therapy in the I-SPY2 neoadjuvant clinical trial
Year: 2021
Type: conference-abstract
Source: Cancer Research
Authors: Douglas Yee, Paul Haluska, Denise M Wolf, Christina Yau, Amy Wilson, Angela DeMichele, Claudine Isaacs, Jane Perlmutter, Joan Venticinque, Hope S Rugo, Richard Schwab, Nola M Hylton, W Fraser Symmans, Michelle E Melisko, Teresa L Helsten, Laura J van't Veer, Donald A Berry, Laura J Esserman
Institutions: University of Minnesota, Masonic Cancer Center, Bristol-Myers Squibb (United States), University of California, San Francisco, Quantum Leap Healthcare Collaborative, University of Pennsylvania, Georgetown University, University of California San Diego, The University of Texas MD Anderson Cancer Center, Berry Consultants, LLC (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3131699005